Investigation summary: dhr review for batch 6209600 (p/n (b)(4)): manufacturing dates: 08/07/2016 ¿ 8/08/2016.All visual inspections were performed as per requirement with no quality notifications related to the complaint defect.Batch 6209600 was inspected and accepted based on meeting our inspection control plan and subsequently approved for shipment.Sample evaluation: five loose 1ml s/t assembled syringes with needles were received by bd canaan and reported to be from batch #6209600 (p/n (b)(4)).The samples were visually evaluated.No visual defects observed.Shield removal testing was performed on all 5 samples.All results were within specified range 0.5 lbs ¿ 5.5lbs per product specification.Refer to results below.Sample 1 - 3.35 lbs, sample 2 - 3.13 lbs, sample 3 - 1.84 lbs, sample 4 - 2.82lbs, sample 5 - 2.78lbs.Based on the sample evaluation: unconfirmed: bd (b)(4) was not able to duplicate or confirm the customer's indicated failure.Complaints received for this product and condition will continue to be tracked and trended.Information will be captured on trend reports and monitored.Our business regularly reviews the collected data for identification of emerging trends.Based on the severity assigned to this complaint and the results of the complaint lot history check, capa is not required at this time.
|